-
Uncategorized2 months ago
Tortugas debuts with $106M and brain drugs from Hansoh, Eisai
Led by former Sage Therapeutics executives Jeff Jonas and Al Robichaud, the company is starting out with a portfolio of neurological medicines in clinical testing.
-
Uncategorized2 months ago
Merck’s Welireg combo fails in first-line kidney cancer
Adding Merck’s Welireg to an existing Keytruda regimen didn’t lead to a significant improvement in newly diagnosed patients with advanced kidney cancer, Merck announced on Tuesday....
-
Uncategorized2 months agoMerck’s fast-ascending kidney cancer drug hits a setback
Welireg’s failure in first-line kidney cancer removes a blockbuster opportunity and could leave an opening for a rival drug from Arcus Biosciences, analysts said. Read More
-
Uncategorized2 months ago
UnitedHealth breaks down how it plans to spend $1.5B on AI
UnitedHealth breaks down how it plans to spend $1.5B on AI
-
Uncategorized2 months agoNavigating with Excellence: The Multi-Faceted Service Lines of Precision Logistics
The global pharmaceutical industry operates within one of the most demanding and high-stakes environments of our modern world. Unlike traditional retail supply chains, pharmaceutical logistics is...
-
Uncategorized2 months ago
FDA approves once-daily HIV pill from Merck
A new HIV treatment will soon come to market, and it will spearhead Merck’s attempt to be one of the leading drugmakers in a field many...
-
Uncategorized2 months agoFlu vaccine no longer mandated for U.S. troops, defense secretary says
WASHINGTON — Defense Secretary Pete Hegseth announced Tuesday that the U.S. military will no longer require all American troops to get the flu vaccine, citing “medical...
-
Uncategorized2 months agoNomic and Broad Clinical Labs to build proteomics platform
Biotechnology company Nomic Bio has announced a partnership with Broad Clinical Labs (BCL) to build a scalable proteomics platform. The organisations will look to integrate Nomic’s...
-
Uncategorized2 months ago
‘It’s just the beginning’ for pancreatic cancer’s long-awaited breakthrough
SAN DIEGO — Since Herceptin’s approval in 1998, breast cancer has been reshaped from a near-term death sentence into — in many cases — a chronic...
-
Uncategorized2 months agoSTAT+: RFK Jr. to face four GOP doctors at Senate hearings
You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health and medicine. Sign up here to receive it in your...
SonoThera Raises $125M to Develop Ultrasound-Mediated Genetic Medicines
